Vyne Therapeutics Inc (VYNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Sales | 0 | 0 | 308 | -7,045 | 0 |
| Gross Profit | N/A | N/A | 308 | -7,045 | N/A |
| Operating Expenses | 23,199 | 19,359 | 16,192 | 31,752 | 13,702 |
| Operating Income | -23,199 | -19,359 | -15,884 | -38,797 | -13,702 |
| Interest Expense | 343 | 102 | 32 | 0 | 0 |
| Other Income | 381 | 468 | 536 | -1,303 | 855 |
| Pre-tax Income | -23,161 | -18,993 | -15,380 | -40,100 | -12,847 |
| Income Tax | 0 | 0 | -176 | N/A | N/A |
| Net Income Continuous | -23,161 | -18,993 | -15,204 | -40,312 | -12,847 |
| Net Income | $-23,161 | $-18,993 | $-15,204 | $-40,312 | $-12,847 |
| EPS Basic Total Ops | -16.55 | -13.67 | -33.81 | -88.31 | -40.29 |
| EPS Basic Continuous Ops | -16.53 | -13.94 | -33.96 | -88.02 | -40.22 |
| EPS Diluted Total Ops | -16.55 | -13.67 | -33.81 | -88.31 | -40.29 |
| EPS Diluted Continuous Ops | -16.53 | -13.94 | -33.96 | -88.02 | -40.22 |
| EBITDA(a) | $-23,106 | $-19,272 | $-15,808 | $-37,937 | $-13,929 |